BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CDK12, KIAA0904, CRKRS, 51755, ENSG00000167258, CRK7, CRKR, Q9NYV4 AND Treatment
13 results:

  • 1. E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma.
    Liu K; Wang L; Lou Z; Guo L; Xu Y; Qi H; Fang Z; Mei L; Chen X; Zhang X; Shao J; Xiang X
    Biochem Pharmacol; 2023 Dec; 218():115854. PubMed ID: 37863324
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cdk12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.
    Liu X; Liu Y; Chai W; Yan M; Li H; Li J; Sun L; Cao Y; Liu Q; Sun Y; Pan H
    Mol Cell Probes; 2023 Oct; 71():101923. PubMed ID: 37517598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PhosphoDisco: A Toolkit for Co-regulated Phosphorylation Module Discovery in Phosphoproteomic Data.
    Schraink T; Blumenberg L; Hussey G; George S; Miller B; Mathew N; González-Robles TJ; Sviderskiy V; Papagiannakopoulos T; Possemato R; Fenyö D; Ruggles KV
    Mol Cell Proteomics; 2023 Aug; 22(8):100596. PubMed ID: 37394063
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
    Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
    BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Poor prognosis of male triple-positive breast cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Isoorientin induces the apoptosis and cell cycle arrest of A549 human lung cancer cells via the ROS‑regulated MAPK, STAT3 and NF‑κB signaling pathways.
    Xu WT; Shen GN; Li TZ; Zhang Y; Zhang T; Xue H; Zuo WB; Li YN; Zhang DJ; Jin CH
    Int J Oncol; 2020 Aug; 57(2):550-561. PubMed ID: 32626938
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.
    Dukaew N; Konishi T; Chairatvit K; Autsavapromporn N; Soonthornchareonnon N; Wongnoppavich A
    Oncol Res; 2020 Mar; 28(2):161-175. PubMed ID: 31727206
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic lung Adenocarcinoma and Validate a Novel Somatic Mutation cdk12-G879V.
    Zhang X; Nguyen KD; Rudnick PA; Roper N; Kawaler E; Maity TK; Awasthi S; Gao S; Biswas R; Venugopalan A; Cultraro CM; Fenyö D; Guha U
    Mol Cell Proteomics; 2019 Apr; 18(4):622-641. PubMed ID: 30617155
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anti-proliferative effect of 8α-tigloyloxyhirsutinolide-13-O-acetate (8αTGH) isolated from Vernonia cinerea on oral squamous cell carcinoma through inhibition of STAT3 and STAT2 phosphorylation.
    Pouyfung P; Choonate S; Wongnoppavich A; Rongnoparut P; Chairatvit K
    Phytomedicine; 2019 Jan; 52():238-246. PubMed ID: 30599904
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of cyclin B1, D1 and K in non‑small cell lung cancer H1299 cells following treatment with sulforaphane.
    Żuryń A; Krajewski A; Klimaszewska-Wiśniewska A; Grzanka A; Grzanka D
    Oncol Rep; 2019 Feb; 41(2):1313-1323. PubMed ID: 30535470
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Structural Alterations Driving Castration-Resistant Prostate cancer Revealed by Linked-Read Genome Sequencing.
    Viswanathan SR; Ha G; Hoff AM; Wala JA; Carrot-Zhang J; Whelan CW; Haradhvala NJ; Freeman SS; Reed SC; Rhoades J; Polak P; Cipicchio M; Wankowicz SA; Wong A; Kamath T; Zhang Z; Gydush GJ; Rotem D; ; Love JC; Getz G; Gabriel S; Zhang CZ; Dehm SM; Nelson PS; Van Allen EM; Choudhury AD; Adalsteinsson VA; Beroukhim R; Taplin ME; Meyerson M
    Cell; 2018 Jul; 174(2):433-447.e19. PubMed ID: 29909985
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer.
    Zhang K; Zhang M; Zhu J; Hong W
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C186-C190. PubMed ID: 28230015
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
    Biswas R; Gao S; Cultraro CM; Maity TK; Venugopalan A; Abdullaev Z; Shaytan AK; Carter CA; Thomas A; Rajan A; Song Y; Pitts S; Chen K; Bass S; Boland J; Hanada KI; Chen J; Meltzer PS; Panchenko AR; Yang JC; Pack S; Giaccone G; Schrump DS; Khan J; Guha U
    Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001263. PubMed ID: 27900369
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.